Canaccord Genuity Upgrades Progyny to Buy, Raises Price Target to $30
Benzinga Newsdesk 5 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Canaccord Genuity analyst Richard Close upgrades Progyny (NASDAQ:PGNY) from Hold to Buy and raises the price target from $19 to $30.
Canaccord Genuity analyst Richard Close upgrades Progyny (NASDAQ:PGNY) from Hold to Buy and raises the price target from $19 to $30.